Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samantha Bruno

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Biomarker Research|March 9, 2023
SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targetedManuela Mancini, Cecilia Monaldi, Sara De Santis, et al.
Oncology Reports|July 13, 2026
[Retracted] Kevetrin induces apoptosis in <i>TP53</i> wild‑type and mutant acute myeloid leukemia cellsRoberta Napolitano, Serena De Matteis, Silvia Carloni, et al.
Oncology Reports|September 18, 2020
Kevetrin induces apoptosis in TP53 wild‑type and mutant acute myeloid leukemia cellsRoberta Napolitano, Serena De Matteis, Silvia Carloni, et al.
Frontiers in Oncology|April 26, 2021
Corrigendum: Denatonium as a Bitter Taste Receptor Agonist Modifies Transcriptomic Profile and Functions of Acute Myeloid Leukemia CellsValentina Salvestrini, Marilena Ciciarello, Valentina Pensato, et al.
Frontiers in Oncology|August 15, 2020
Denatonium as a Bitter Taste Receptor Agonist Modifies Transcriptomic Profile and Functions of Acute Myeloid Leukemia CellsValentina Salvestrini, Marilena Ciciarello, Valentina Pensato, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 1, 2021
Distinct profile of CD34<sup>+</sup> cells and plasma-derived extracellular vesicles from triple-negative patients with Myelofibrosis reveals potential markers of aggressive diseaseDorian Forte, Martina Barone, Cristina Morsiani, et al.
Cancers|November 14, 2019
Synergism Through WEE1 and CHK1 Inhibition in Acute Lymphoblastic LeukemiaAndrea Ghelli Luserna Di Rorà, Matteo Bocconcelli, Anna Ferrari, et al.
Frontiers in Oncology|October 18, 2021
Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid LeukemiaSamantha Bruno, Lorenza Bandini, Agnese Patuelli, et al.
International Journal of Molecular Sciences|September 28, 2024
Tracking Response and Resistance in Acute Myeloid Leukemia through Single-Cell DNA Sequencing Helps Uncover New Therapeutic TargetsSamantha Bruno, Enrica Borsi, Agnese Patuelli, et al.
Vaccines|September 23, 2022
Lessons Learned from the Development and Roll-Out of the rVSVΔG-ZEBOV-GP <i>Zaire ebolavirus</i> Vaccine to Inform Marburg Virus and <i>Sudan ebolavirus</i> VaccinesBeth-Ann G Coller, William Lapps, Mahum Yunus, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Biomarker Research|March 9, 2023
SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targetedManuela Mancini, Cecilia Monaldi, Sara De Santis, et al.
Oncology Reports|July 13, 2026
[Retracted] Kevetrin induces apoptosis in <i>TP53</i> wild‑type and mutant acute myeloid leukemia cellsRoberta Napolitano, Serena De Matteis, Silvia Carloni, et al.
Oncology Reports|September 18, 2020
Kevetrin induces apoptosis in TP53 wild‑type and mutant acute myeloid leukemia cellsRoberta Napolitano, Serena De Matteis, Silvia Carloni, et al.
Frontiers in Oncology|April 26, 2021
Corrigendum: Denatonium as a Bitter Taste Receptor Agonist Modifies Transcriptomic Profile and Functions of Acute Myeloid Leukemia CellsValentina Salvestrini, Marilena Ciciarello, Valentina Pensato, et al.
Frontiers in Oncology|August 15, 2020
Denatonium as a Bitter Taste Receptor Agonist Modifies Transcriptomic Profile and Functions of Acute Myeloid Leukemia CellsValentina Salvestrini, Marilena Ciciarello, Valentina Pensato, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 1, 2021
Distinct profile of CD34<sup>+</sup> cells and plasma-derived extracellular vesicles from triple-negative patients with Myelofibrosis reveals potential markers of aggressive diseaseDorian Forte, Martina Barone, Cristina Morsiani, et al.
Cancers|November 14, 2019
Synergism Through WEE1 and CHK1 Inhibition in Acute Lymphoblastic LeukemiaAndrea Ghelli Luserna Di Rorà, Matteo Bocconcelli, Anna Ferrari, et al.
Frontiers in Oncology|October 18, 2021
Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid LeukemiaSamantha Bruno, Lorenza Bandini, Agnese Patuelli, et al.
International Journal of Molecular Sciences|September 28, 2024
Tracking Response and Resistance in Acute Myeloid Leukemia through Single-Cell DNA Sequencing Helps Uncover New Therapeutic TargetsSamantha Bruno, Enrica Borsi, Agnese Patuelli, et al.
Vaccines|September 23, 2022
Lessons Learned from the Development and Roll-Out of the rVSVΔG-ZEBOV-GP <i>Zaire ebolavirus</i> Vaccine to Inform Marburg Virus and <i>Sudan ebolavirus</i> VaccinesBeth-Ann G Coller, William Lapps, Mahum Yunus, et al.
Pageof 4